Associate ProfessorOwen Marshall

Principal Research Fellow

Menzies Institute for Medical Research

RESEARCH SUMMARy

We are interested in the epigenetic make-up of neuronal populations within the brain, and how the chromatin structure of these neurons changes during development, neurodegenerative disease and ageing. We seek to answer questions such as: What happens to neurons during Alzheimer’s Disease progression? What causes brain cancers to form, and how can we fight and cure these tumours? What changes occur in the brain during the ageing process?

Within a cell, the activation of genes depends ultimately on their epigenetic environment. DNA is wrapped around nucleosomes to form chromatin, which can either be opened up to allow transcription factors to bind and genes to be transcribed, or condensed to shut down gene expression. By regulating the transitions between open and closed chromatin, great variation in the transcriptome of a cell can be achieved, even when expressing many of the same transcription factors.

A number of studies over the last decade have shown that different forms of chromatin are regulated through combinations of chromatin-modifying proteins and the epigenetic histone modification marks that these proteins read or write. Together, these combinations of histone marks and chromatin proteins create what have been termed “chromatin states”. However, how these forms of chromatin control gene regulation in complex organs such as the brain remains largely unknown.

We use the vinegar fly Drosophila melanogaster as a powerful model organism with which to study the brain, combined with cutting-edge tools such as Targeted DamID (TaDa) and bioinformatic analyses. Using TaDa and other techniques, we can profile both the transcriptome and genome-wide chromatin states of individual subtypes of neurons within the brain with extraordinarily fine temporal and spatial control. We can also ask where key transcription factors bind in individual cell types. With cell-type specific transcriptome, chromatin and transcription factor data, we can begin to map out the regulatory networks within the brain.

FUNDED PROJECTS

  • GRANT
    Uncovering new genetic and epigenetic drivers of brain cancer
    1 Jul 2026 - 30 Jun 2027
    People funded by this grant:
    • Marshall O,
    • Harrup R,
    • Dickinson J,
    • FitzGerald L
    Project Total: $143,999; The most common and aggressive form of adult brain cancer, glioblastoma, has devastating outcomes, and treatments have not improved significantly in decades. This leaves patients and their families with few effective options. Our project is trying to solve two fundamental problems: we do not fully understand what causes these tumours to form, and we lack effective drugs that can stop their growth. Our research tackles this by asking two key questions. First, why do some families have a higher rate of brain cancer? By studying Tasmanian families with a history of brain cancer, we aim to find specific inherited genes that increase a person's risk. Identifying these genes helps us uncover new causes of brain cancer, and could lead to better screening for families. Second, what cellular processes help cells become cancerous and grow uncontrollably? We are investigating the on/off switches that control genes inside the cancer cells. We have already found one of these master switches, a protein complex called SWI/SNF, that appears to be critical for tumour growth. To test our discoveries, we use fast-acting animal models of disease that allow us to see if a human gene variant causes cancer-like growth, or if a drug can stop it, in just a few weeks. This work directly addresses the urgent need for new therapies. By finding the underlying causes of brain cancer, we can identify individuals at higher risk, uncover new targets for drug development, and test potential new treatments more quickly, bringing much-needed hope to the brain cancer community. Funded by: Walter and Eliza Hall Institute of Medical Research - BCC Program 2025 Funding ($143,999); University of Tasmania.
  • GRANT
    Uncovering the genetic drivers of brain cancer in Tasmanians
    1 Jan 2026 - 30 Jun 2027
    People funded by this grant:
    • Marshall O,
    • Harrup R,
    • Dickinson J,
    • Thani N,
    • FitzGerald L
    Project Total: $99,955; Glioblastoma (GBM) remains the most lethal primary brain tumour in Tasmania, with limited therapeutic options and a pressing need for locally relevant research. This proposal builds on the Tasmanian Central Nervous System (CNS) Cancers Biobank established by CIs Harrup and Dickinson, and the unique cohort of extended Tasmanian families with inherited brain cancer, to provide an integrated, 18-month programme that links clinical genetics, high-throughput sequencing, and rapid Drosophila functional assays. The clinical team at Royal Hobart Hospital (RHH) will identify families with multiple cases of brain cancer and to obtain fresh-frozen tumour and blood samples through the Biobank. This effort will be led by CIHarrup (medical oncologist) and supported by CIGupta (consultant), CIRagg (registrar), and CIThani (neurosurgeon). Whole-genome sequencing of these families, performed by the Menzies Cancer Genetics group under CIDickinson, will uncover rare, high-risk variants that are under-represented in national datasets. Candidate genes will be prioritised on the basis of segregation, predicted impact, and relevance to known GBM pathways. Concurrently, the Menzies Neuroepigenetics group led by CIMarshall will generate humanised transgenic Drosophila that express the patient-derived variants in an established IDH-wildtype GBM model. Using inducible genetic systems, we will assess each variants effect on neural proliferation, tumour-like overgrowth, and epigenetic reprogramming. A parallel effort will create a novel IDH-mutant (R132H) GBM model, enabling direct comparison of variant function across the two major molecular subtypes of GBM. The fly assays are rapid, fully quantitative, reproducible, and amenable to medium-throughput drug screening, allowing us to test candidate therapeutics for blood-brain barrier penetration and tumour suppression. The grant will also support a postdoctoral researcher, Jake Newland, to drive the Drosophila functional work and integrate the findings with clinical data. The project will deliver three tangible outcomes for Tasmanian health: (1) a curated catalogue of rare, familial GBM variants linked to clinical phenotypes; (2) validated Drosophila models that provide rapid functional insight and a platform for pre-clinical drug testing; and (3) a translational pipeline that ulitmately will inform precision-medicine strategies for patients treated at RHH. By integrating local clinical expertise with cutting-edge genetics and in vivo functional genomics, the programme directly addresses the Foundations priorities of improving cancer outcomes, strengthening RHH research capacity, and fostering interdisciplinary collaboration across senior and junior investigators. Funded by: Royal Hobart Hospital Research Foundation - Research Project Grant ($99,955); University of Tasmania.
  • GRANT
    Uncovering new genetic and epigenetic drivers of brain cancer
    1 Jan 2025 - 31 Jan 2026
    People funded by this grant:
    • Marshall O,
    • Harrup R,
    • Dickinson J
    Project Total: $144,000; Our research program aims to advance understanding of genetic and epigenetic mechanisms in glioblastoma (GBM). Leveraging genetic profiling of Tasmanias unique, multi-generational families combined with rapid Drosophila models of the disease, we aim to identify novel therapeutic targets. Key objectives include biobanking Tasmanian CNS tumour tissue, mapping linked familial mutations, and using fly models to investigate the roles of these genetic variants. We will also screen the role of epigenetic modifiers known to be dysregulated in brain tumours and the action of epigenetic inhibitor drugs. Expected outcomes include identifying novel drivers of GBM, developing new therapeutic strategies and enhancing research tools for understanding brain cancer. Funded by: Walter and Eliza Hall Institute of Medical Research - BCC Program 2025 Funding ($144,000); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    CNS Cancers Tasmania Program
    1 Jan 2024 - 31 Dec 2025
    People funded by this grant:
    • Dickinson J,
    • Marshall O,
    • Taberlay P,
    • Young K,
    • Dickson T
    Project Total: $97,812; To map the genetic and epigenetic changes that drive brain tumour development. Funded by: Walter and Eliza Hall Institute of Medical Research ($97,812); University of Tasmania.
  • GRANT
    Wake up call: deciphering the regulatory networks that reactivate neural stem cells
    1 Jan 2024 - 31 Dec 2027
    People funded by this grant:
    • Marshall O,
    • Stumpf M,
    • Furlong,
    • Paulsen J
    Project Total: $1,345,764; Neural stem cells generate the major cell populations within our brain: neurons and glia. However, during much of our lives they enter a suspended state termed quiescence. Understanding how quiescence is maintained within the brain is vital for understanding and aiding how our brain recovers from injury or trauma. This project will uncover the complex regulatory networks and structures that make quiescence possible, and identify new factors that allow reactivation from the quiescent state. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($2,691,528); University of Tasmania ($388,448).
  • GRANT
    There and back again: understanding the epigenetic remodelling that turns glia into glioma
    1 Jan 2020 - 31 Dec 2022
    People funded by this grant:
    • Marshall O,
    • Giangrande A
    Project Total: $536,847; Glia are a major cell type within the brain that protect, nourish and insulate neurons. Like neurons, glia are formed via differentiation from neural stem cells. Although differentiation is typically associated with epigenetic locks to prevent a reversal of cell fate, some glia can overcome these inhibitions and differentiate to form glioma tumours capable of rapid proliferation and resistance to treatment. Understanding how glioma cells manage to break out of their chromatin environment jail represents a key means to understanding these tumours and to combating their resistance and lethality. However, the epigenetic changes that occur during glial differentiation and glioma de-differentiation remain a mystery. Here, using the fruit fly as a model organism, together with our new cell-type specific Chromatin TaDa system, we will profile the epigenetic configuration of glial cells within the brain. In order to understand glial differentiation, we will profile the binding of the key cell fate determinant that triggers gliogenesis, Gcm, together with two key epigenetic factors that drive this change, Cbp and the SAGA complex. Finally we will use a well-characterised and relevant fly model of glioma to understand the pathway of differentiation and tumourogenesis. By using of variants of this model to represent different stages of malignancy we will track the epigenetic changes involved in cancer formation. Together with a rapid RNAi screen for chromatin modifying complexes, we will identify the key epigenetic changes to target in interventions. These predictions will be tested on a panel of human glioblastoma cell lines. Our team represents an international collaboration uniquely placed to tackle this problem, consisting of an expert in chromatin states and cell-type specific profiling (CI Marshall), an expert in glia and glial cell fate (CI Giangrande) and experts in glioma and glioma models (AIs Casas Tinto, Quinn and Parsons). Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($1,073,694); University of Tasmania.
  • GRANT
    Chromatin State Changes in Intestinal Stem Cell Ageing
    1 Jan 2019 - 30 Mar 2020
    People funded by this grant:
    • Doupe D,
    • Marshall O
    Project Total: $35,000; Adult stem cells must divide to produce new cells to renew and repair tissues. A failure to produce enough cells could lead to tissue failure while an overproduction of cells can lead to compromised tissue function and cancer. The incidence of colorectal cancer increases with age, suggesting that in ageing intestinal stem cells this balance may be lost. We use the fruit fly gut as a simple model to study intestinal stem cells. Many of the signals and genes that regulate human intestinal stem cells are conserved to fruit flies. In young adult flies the stem cells divide to maintain the gut, but in ageing flies they become mis-regulated and over-proliferate. Changes in cell behaviour such as increased stem cell proliferation usually occur through changes in gene expression. DNA is packaged into structures called chromatin, some forms of chromatin allow gene expression, while others are repressive, causing genes to be switched off. This means that chromatin state plays an important role in stem cell regulation. Individual chromatin components have been shown to regulate stem cells but how chromatin state contributes to stem cell ageing is not known. This project will characterize the changes in chromatin states that occur when intestinal stem cells age. This will improve our understanding of how adult stem cells become mis-regulated with age; a critical process for health and disease. Our work will identify new mechanisms of regulation that could be targeted to improve tissue function with age. Funded by: The Royal Society - Grant; University of Tasmania.
  • UTAS INTERNAL FUNDING
    Confocal Microscopy
    1 Jan 2019 - 31 Dec 2019
    People funded by this grant:
    • Marshall O,
    • Young K
    Project Total: $370,000; Confocal microscope. There is an urgent need for additional confocal microscopes in the Medical Science Precinct research laboratory. By way of example, there is a 2 month waiting list for new users to be trained to use microscopes and a longer waiting period to gain access to image experiments. Funded by: University of Tasmania; University of Tasmania.
  • GRANT
    Imaging to overcome dementia
    21 Sep 2018 - 31 May 2019
    People funded by this grant:
    • Marshall O
    Project Total: $150,000; This grant will enable the purchase of a high-end confocal microscope that will dramatically increase imaging capacity at the Menzies Institute for Medical Research, University of Tasmania. A large number of research groups based at the Menzies are conducting research into the causes of dementia and other neurological diseases, and these will strongly benefit from the acquisition of the new microscope. The microscope will increase both the productivity and impact of the research of these groups, and also enable increased collaborative links between Menzies researchers and national and international partners Funded by: Ian Potter Foundation - Grant - Medical Research ($150,000); University of Tasmania ($343,700).
  • GRANT
    A genome-wide analysis of the epigenetic control of learning and memory
    1 Jan 2017 - 31 Mar 2020
    People funded by this grant:
    • Marshall O,
    • Dickson T,
    • Southall T
    Project Total: $547,857; The ability to form and recall memories is a fundamental function of the brain. This ability is affected by neurodegenerative diseases such as Alzheimer's Disease. This project will uncover the regulatory framework that defines the brain cells involved in forming memories, and how these change during Alzheimer's Disease progression. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($1,095,714); University of Tasmania.